BVF INC/IL - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
BVF INC/IL ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$11,517,000
-71.0%
300,000
-88.3%
0.31%
-78.6%
Q1 2023$39,721,110
-12.6%
2,561,0000.0%1.45%
-24.3%
Q4 2022$45,457,750
+237.7%
2,561,000
+101.1%
1.92%
+280.6%
Q2 2021$13,461,000
-26.6%
1,273,516
+11.3%
0.50%
-26.7%
Q1 2021$18,350,000
-22.8%
1,144,016
+122.4%
0.69%
-26.4%
Q4 2020$23,759,000
-43.7%
514,370
-57.1%
0.94%
-59.3%
Q3 2020$42,173,000
+59.1%
1,198,427
+10.1%
2.30%
+40.6%
Q2 2020$26,504,000
+70.3%
1,088,479
+8.8%
1.63%
+12.6%
Q1 2020$15,565,000
-1.8%
999,9960.0%1.45%
+20.7%
Q4 2019$15,850,000999,9961.20%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,500,000$26,6258.85%
Deep Track Capital, LP 9,710,000$172,352,5007.24%
Logos Global Management LP 3,150,000$55,912,5006.55%
Ikarian Capital, LLC 966,700$17,158,9254.14%
COMMODORE CAPITAL LP 1,150,505$20,4213.08%
TCG Crossover Management, LLC 854,853$15,173,6412.68%
SILVERARC CAPITAL MANAGEMENT, LLC 519,614$9,223,1492.64%
COWEN AND COMPANY, LLC 1,250,000$22,187,5002.32%
BVF INC/IL 2,561,000$45,457,7501.92%
Eventide Asset Management 3,693,720$65,563,5301.29%
View complete list of IMMUNOVANT INC shareholders